Amylin receptors: Molecular composition and pharmacology

Biochemical Society Transactions

Volumn 32, Issue 5, 2004, Pages 865-867

  Hay, D L ^a   Christopoulos, G ^b   Christopoulos, A ^b   Sexton, P M ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Amylin; Calcitonin receptor; RAMP2; RAMP3; Receptor activity modifying protein 1 (RAMP1)

Indexed keywords

AMYLIN; CALCITONIN RECEPTOR; PROTEIN C FOS; RECEPTOR ACTIVITY MODIFYING PROTEIN; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; RECEPTOR ACTIVITY MODIFYING PROTEIN 2; RECEPTOR ACTIVITY MODIFYING PROTEIN 3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA POSTREMA; BINDING AFFINITY; CELL STRAIN COS7; CONFERENCE PAPER; CONTROLLED STUDY; DRINKING BEHAVIOR; GENE EXPRESSION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; SUBFORNICAL ORGAN;

ANIMALS; CLONING, MOLECULAR; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; PEPTIDES; PROTEIN ISOFORMS; RECEPTORS, CALCITONIN; RECEPTORS, PEPTIDE; RNA, MESSENGER; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 8744264162     PISSN: 03005127     EISSN: None     Source Type: Journal    
DOI: 10.1042/BST0320865     Document Type: Conference Paper

References (15)

1. Poyner, D.R., Sexton, P.M., Marshall, I., Smith, D.M., Quirion, R., Born, W., Muff, R., Fischer, J.A. and Foord, S.M. (2002) Pharmacol. Rev. 54, 233-246
2. Cooper, G.J. (1994) Endocr. Rev. 15, 163-201
3. Perry, K.J., Quiza, M., Myers, D.E., Morfis, M., Christopoulos, G. and Sexton, P.M. (1997) Endocrinology 138, 3486-3496
4. Christopoulos, G., Perry, K.J., Morphis, M., Tilakaratne, N., Gao, Y., Fraser, N.J., Main, M.J., Foord, S.M. and Sexton, P.M. (1999) Mol. Pharmacol. 56, 235-242
5. Sexton, P.M., Albiston, A., Morfis, M. and Tilakaratne, N. (2001) Cell. Signal. 13, 73-83
6. Purdue, B.W., Tilakaratne, N. and Sexton, P.M. (2002) Receptors Channels 8, 243-255
7. Tilakaratne, N., Christopoulos, G., Zumpe, E., Foord, S.M. and Sexton, P.M. (2000) J. Pharmacol. Exp. Ther. 294, 61-72
8. Kuwasako, K., Kitamura, K., Nagoshi, Y. and Eto, T. (2003) Biochem. Biophys. Res. Commun. 301, 460-464
9. Beaumont, K., Kenney, M.A. and Rink, T.J. (1993) Mol. Pharmacol. 44, 493-497
10. Gardiner, S.M., Compton, A.M., Kemp, P.A., Bennett, T., Bose, C., Foulkes, R. and Hughes, B. (1991) Diabetes 40, 948-951
11. Leuthauser, K., Gujer, R., Aldecoa, A., McKinney, R.A., Muff, R., Fischer, J.A. and Born, W. (2000) Biochem. J. 351, 347-351
12. Kuwasako, K., Yuan-Ning, C., Nagoshi, Y., Tsuruda, T., Kitamura, K. and Eto, T. (2004) Mol. Pharmacol. 65, 207-213
13. Kuwasako, K., Shimekake, Y., Masuda, M., Nakahara, K., Yoshida, T., Kitaura, M., Kitamura, K., Eto, T. and Sakata, T. (2000) J. Biol. Chem. 275, 29602-29609
14. Barth, S.W., Riediger, T., Lutz, T.A. and Rechkemmer, G. (2004) Brain Res. 997, 97-102
15. Riediger, T., Schmid, H.A., Young, A.A. and Simon, E. (1999) Brain Res. 837, 161-168